Dear Framingham Heart Study Research Community,
The National Heart, Lung, and Blood Institute (NHLBI) has announced plans to fund a limited clinic exam cycle in the Generation 3 and Omni 2 Cohorts of the Framingham Heart Study (FHS).
The examination is expected to begin on or about January 2, 2022. The exam is intended in part to serve as a platform for additional, independently funded exam components via investigator-initiated grants or other independently funded projects to enrich the exam data collection with additional hypothesis-driven content. The research aims of such exam-related ancillary projects need not be limited to those within the mission of the NHLBI but must be consistent with and/or complement FHS study objectives.
Read more: NOT-HL-19-732
Regard the NHLBI Epidemiology Digital Forum: There is a statement in the Notice NOT-HL-19-732: “Further information about application submission timing is available on the NHLBI Epidemiology Digital Forum.”
STEP 1: Review FHS proposal guidance online:
1) Guide for Investigators – II
2) For Researchers section
3) FHS Policies and Procedures section
4) Consider the projections and power calculations provided at the bottom of this page
5) Research Application FAQ (Update Coming Soon)
STEP 2: Apply for FHS Review Committees’ approval prior to your submission to any sponsor. Please apply for FHS approval online via the FHS Research Application
STEP 3: Apply for sponsorship. If you are interested in NIH funding, our Project Officers recommended the following R01 application dates posted below.
If you have questions and/or comments, please contact FHS@bu.edu
Framingham Heart Study
Boston University School of Medicine
Please see below for projections of the numbers of participants for the Gen 3 Exam 4 exam cycle (n=3374), breakdowns by cohort, sex, age group and race/ethnicity, and power calculations for various types of analyses.